MAT2A Gene Aortic Aneurysm Test USA | $500 | NGS Genetic Testing for Familial Thoracic Aortic Disease
SFTPA1 Gene Pulmonary Fibrosis Idiopathic NGS Genetic DNA Test - $500 USA | Comprehensive Genetic Testing for Idiopathic Pulmonary Fibrosis SFTPA1 Gene Pulmonary Fibrosis Idiopathic NGS Genetic DNA Test Original price was: $700.Current price is: $500.
GP1BA Gene Bernard-Soulier Syndrome Type A2 NGS Test - $500 USA | Genetic Testing for Bleeding Disorders GP1BA Gene Bernard-Soulier Syndrome Type A2 NGS Genetic DNA Test Original price was: $700.Current price is: $500.
Sale!

MAT2A Gene Aortic Aneurysm Familial Thoracic NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MAT2A Gene Aortic Aneurysm Familial Thoracic NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the MAT2A gene associated with familial thoracic aortic aneurysms. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that predispose individuals to life-threatening aortic conditions. The test is particularly important for individuals with family history of aortic diseases or unexplained thoracic symptoms. Early detection through this $500 USD test enables proactive medical management and preventive strategies. Results are typically available within 3-4 weeks from blood or DNA samples. Genetic counseling is recommended before testing to understand familial patterns and implications.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MAT2A Gene Aortic Aneurysm Familial Thoracic NGS Genetic DNA Test

Comprehensive Genetic Testing for Thoracic Aortic Health

The MAT2A Gene Aortic Aneurysm Familial Thoracic NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics, offering precise detection of mutations associated with inherited thoracic aortic aneurysms. This advanced testing methodology provides crucial insights for individuals at risk of developing life-threatening aortic conditions, enabling early intervention and personalized medical management strategies.

What This Test Measures and Detects

Our specialized NGS genetic test specifically targets the MAT2A gene, which plays a critical role in methionine metabolism and cardiovascular development. The test identifies:

  • Pathogenic variants in the MAT2A gene associated with familial thoracic aortic aneurysms
  • Single nucleotide polymorphisms (SNPs) affecting aortic wall integrity
  • Genetic mutations that predispose individuals to aortic dissection risk
  • Inherited patterns of thoracic aortic disease susceptibility
  • Specific genetic markers linked to progressive aortic dilation

Who Should Consider This Genetic Test

This comprehensive genetic evaluation is recommended for individuals experiencing:

  • Family history of thoracic aortic aneurysms or dissections
  • Unexplained chest pain or thoracic discomfort
  • Connective tissue disorder symptoms without clear diagnosis
  • Multiple family members with cardiovascular conditions
  • Previous aortic imaging showing dilation or abnormalities
  • Young-onset cardiovascular events in family members
  • Genetic predisposition concerns for aortic health

Significant Benefits of MAT2A Genetic Testing

Undergoing this specialized genetic assessment provides numerous advantages:

  • Early Risk Identification: Detect genetic predisposition before symptoms manifest
  • Personalized Monitoring: Establish appropriate screening intervals based on genetic risk
  • Family Planning Guidance: Understand inheritance patterns for future generations
  • Targeted Prevention: Implement lifestyle and medical interventions specific to genetic risk
  • Peace of Mind: Reduce uncertainty through definitive genetic information
  • Comprehensive Care Planning: Coordinate with cardiovascular specialists for optimal management

Understanding Your Genetic Test Results

Our genetic counseling team provides comprehensive interpretation of your MAT2A test results:

  • Positive Result: Indicates presence of MAT2A mutation; requires regular aortic monitoring and specialist consultation
  • Negative Result: No detected MAT2A mutations; continue standard cardiovascular health practices
  • Variant of Uncertain Significance: Requires ongoing research and periodic re-evaluation
  • Carrier Status: Important for family planning and relative risk assessment

All results include detailed explanations and recommendations for next steps in your healthcare journey.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Accessibility

We maintain comprehensive testing facilities across major metropolitan areas throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures convenient access to advanced genetic testing services regardless of your location.

Take Control of Your Cardiovascular Health

Don’t wait for symptoms to develop. Proactive genetic testing for MAT2A-related thoracic aortic aneurysms provides the knowledge needed to protect your cardiovascular health and potentially save lives. Our experienced genetic counselors and cardiovascular specialists are ready to guide you through the testing process and help interpret your results within the context of your personal and family medical history.

Ready to schedule your genetic consultation? Contact our dedicated healthcare team today at +1(267) 388-9828 or book your appointment online to begin your journey toward comprehensive cardiovascular risk assessment and personalized health management.

SKU: 68d3743587f7 Category:

Related products